
AbbVie's approach to innovation builds on an impressive track record of developing breakthrough science. AbbVie scientists discovered and developed two important medications to treat HIV, helping to change the outlook for many patients with this disease. Our work in immunology has benefitted patients with rheumatoid arthritis, psoriasis, Crohn's disease, and other chronic, autoimmune conditions. We continue to advance scientific research across many disease areas.
Our expertise in both small molecules and biologics allows us to find and pursue the best solution for many diseases.
AbbVie is designing adaptive clinical trials to make our clinical trials smarter, faster, and more efficient.
New methods such as biochemical markers and imaging technologies are helping us evaluate the effectiveness of our compounds.
We also know how important collaborative R&D agreements and partnerships are to speed up medical breakthroughs. To find potential new therapies for patients we look both inside and outside AbbVie to help uncover promising discoveries. We partner and collaborate with peer companies, universities, non-governmental organizations, and others to help find solutions for patients around the globe. At AbbVie, we understand there are times when we can accomplish more together than alone.
YOU ARE ABOUT TO LEAVE FOR A 3RD PARTY WEBSITE
Notice
The "Yes" link below will take you out of the AbbVie family of websites.
Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.
The Internet site that you have requested may not be optimized to your screen size.
Do you wish to leave this site?
EXIT ABBVIE.COM
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site.
As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence.
The Internet site that you have requested may not be optimized to your screen size.
Do you wish to continue to this product-specific site?